Literature DB >> 12691354

Thromboprophylaxis in surgical patients.

Martin O'Donnell1, Jeffrey I Weitz.   

Abstract

Venous thromboembolism is the most common preventable cause of death in surgical patients. Thromboprophylaxis, using mechanical methods to promote venous outflow from the legs and antithrombotic drugs, provides the most effective means of reducing morbidity and mortality in these patients. Despite the evidence supporting thromboprophylaxis, it remains underused because surgeons perceive that the risk of venous thromboembolism is not high enough to justify the potential hemorrhagic complications of anticoagulant use. The risk of venous thromboembolism is determined by patient characteristics and by the type of surgery that is performed. In this paper we identify the risk factors for venous thromboembolism and provide a scheme for stratifying surgical patients according to their risk. We describe the mechanism of action of the various forms of thromboprophylaxis and outline the evidence supporting thromboprophylaxis in different surgical settings. Finally, we recommend optimal forms of thromboprophylaxis in patients who undergo various types of surgery. Intermittent pneumatic compression, with or without elastic stockings, can be used for thromboprophylaxis in patients who undergo neurosurgical procedures; for patients who undergo vascular or cardiovascular procedures, long-term acetylsalicylic acid should be used for thromboprophylaxis. Low-molecular-weight heparin (LMWH) or warfarin is the choice for patients with spinal cord operations and all patients with major trauma who do not have contraindications to anticoagulation should receive thromboprophylaxis with LMWH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691354      PMCID: PMC3211697     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  15 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Elastic compression stockings for prevention of deep vein thrombosis.

Authors:  S V Amaragiri; T A Lees
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 3.  Heparin.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

4.  Prevention of thromboembolism in spinal cord injury. Consortium for Spinal Cord Medicine.

Authors: 
Journal:  J Spinal Cord Med       Date:  1997-07       Impact factor: 1.985

Review 5.  Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice.

Authors:  A G Turpie
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

6.  A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors:  W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

7.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

8.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

9.  A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.

Authors:  R Hull; G Raskob; G Pineo; D Rosenbloom; W Evans; T Mallory; K Anquist; F Smith; G Hughes; D Green
Journal:  N Engl J Med       Date:  1993-11-04       Impact factor: 91.245

10.  Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients.

Authors:  S E Dismuke; E H Wagner
Journal:  JAMA       Date:  1986-04-18       Impact factor: 56.272

View more
  13 in total

1.  Use of Prophylactic Inferior Vena Cava Filters in Trauma.

Authors:  Ahmed A Naiem; Alreem K Al-Hinai; Rashid Al-Sukaiti; Hani Al-Qadhi
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

Review 2.  Impact of drugs on venous thromboembolism risk in surgical patients.

Authors:  Alenka Premuš Marušič Kovačič; Martin Caprnda; Aleš Mrhar; Peter Kubatka; Igor Locatelli; Barbora Zolakova; Ludovit Gaspar; Robert Prosecky; Peter Kruzliak; Robert Staffa; Luis Rodrigo; Jozef Radonak; Danijel Petrovič
Journal:  Eur J Clin Pharmacol       Date:  2019-02-05       Impact factor: 2.953

3.  Low-molecular weight vs. unfractionated heparin for prevention of venous thromboembolism in general surgery: a meta-analysis.

Authors:  Prachi Nair; Radhika Trivedi; Patrick Hu; Yingting Zhang; Aziz M Merchant
Journal:  Updates Surg       Date:  2020-09-03

4.  A Real-World Comparative Effectiveness Analysis of Thromboprophylactic Use of Enoxaparin Versus Unfractionated Heparin in Abdominal Surgery Patients in a Large U.S. Hospital Database.

Authors:  S P Veeranki; Z Xiao; A Levorsen; M Sinha; B Shah
Journal:  Hosp Pharm       Date:  2021-01-19

5.  Infraumbilical anterior retroperitoneal exposure of the lumbar spine in 128 consecutive patients.

Authors:  Luke Brewster; Nathan Trueger; Carol Schermer; Alex Ghanayem; John Santaniello
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

6.  The Effect of Deep Vein Thrombosis Prophylaxis on Bleeding in Periorbital Surgery in Trauma Patients.

Authors:  Timothy Charles Woernley; Blake Maida; James Melville; Jose Marchena; Nagi Demian
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2019-03-19

7.  Thromboprophylaxis in Intramedullary Limb Lengthening Surgery.

Authors:  Alexios D Iliadis; Anna Timms; Sharron Fugazzotto; Penina Edel; Simon Britten; Jonathan Wright; David Goodier; Peter Calder
Journal:  Strategies Trauma Limb Reconstr       Date:  2020 Sep-Dec

8.  Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center.

Authors:  Ghazwa B Korayem; Omar A Alshaya; Norah S Alsubaie; Dalal A Alabdulkarim; Omar A Almohammed; Osamah M Alfayez; Majed S Al Yami
Journal:  Saudi Pharm J       Date:  2021-04-28       Impact factor: 4.330

9.  Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study.

Authors:  Hassan Assareh; Jack Chen; Lixin Ou; Stephanie J Hollis; Kenneth Hillman; Arthas Flabouris
Journal:  BMJ Open       Date:  2014-10-03       Impact factor: 2.692

10.  Low Risk of Thromboembolic Complications After Fast-Track Abdominal Surgery With Thrombosis-Prophylaxis Only During Hospital Stay.

Authors:  Arne Christian Mohn; Jon Egge; Ola Rokke
Journal:  Gastroenterology Res       Date:  2011-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.